Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.
about
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic EffectsTransition metals and mitochondrial metabolism in the heartSulforaphane protects the heart from doxorubicin-induced toxicityMice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity.Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms.Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.Upregulation of peroxiredoxin III in doxorubicin-induced cytotoxicity and the FoxO3a-dependent expression in H9c2 cardiac cells.Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host.Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumorsAll-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathwayThe role of iron in anthracycline cardiotoxicity.Hydrogen sulfide inhibits the translational expression of hypoxia-inducible factor-1α.TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy.
P2860
Q26742059-94A912A2-AE12-4D4B-ADE6-1506FF351438Q26752455-A6043299-3BB3-42B4-A758-52D126DDD345Q26999334-8B78D63C-7C23-4972-BEEB-3FB523F6F668Q28387218-84A79BDD-5FAD-4DEE-877F-988B4FB672B1Q33985016-4916EE00-91D8-4554-9252-1A99B1D87EB4Q35078142-0BD4EF79-ABDE-4774-BEDF-54183F629EDBQ35296244-E5C6B491-5603-4690-B102-934116295C75Q35763055-7BCF1460-E67B-40A4-BD7E-26DFEF07B31FQ35856669-13E13096-4958-4EAA-AF28-B34270704F6BQ36153375-782E6C96-A660-47DC-9B03-89EC0D04C33BQ36318719-1AEAD8B9-5E9F-49A4-89CE-0770261A9106Q36568915-02972C8C-9C18-4D6A-8EED-28D76CF139D0Q37190433-E26F5B44-3D38-499C-B233-7FEAF7D48584Q37686126-09E73CBD-D7BA-4C8B-8A7A-E6EB17488F1FQ38195038-7C429E54-9460-4FF8-BBFB-D898D60F7722Q39308399-90CC8E97-F9F3-484A-8A59-48D55EEE5160Q41252402-EC74BEC9-9B9A-4F84-B2C1-685D9F9D7A5C
P2860
Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@en
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@nl
type
label
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@en
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@nl
prefLabel
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@en
Role of hypoxia-inducible fact ...... doxorubicin-induced toxicity.
@nl
P2860
P50
P1476
Role of hypoxia-inducible fact ...... m doxorubicin-induced toxicity
@en
P2093
R D Spagnuolo
S Recalcati
P2860
P304
P356
10.1111/J.1476-5381.2011.01208.X
P407
P577
2011-05-01T00:00:00Z